Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Nov 9, 2020
Date Accepted: Apr 17, 2021

The final, peer-reviewed published version of this preprint can be found here:

Guided Internet-Based Cognitive Behavioral Therapy for Insomnia: Health-Economic Evaluation From the Societal and Public Health Care Perspective Alongside a Randomized Controlled Trial

Buntrock C, Lehr D, Smit F, Horvath H, Berking M, Spiegelhalder K, Riper H, Ebert DD

Guided Internet-Based Cognitive Behavioral Therapy for Insomnia: Health-Economic Evaluation From the Societal and Public Health Care Perspective Alongside a Randomized Controlled Trial

J Med Internet Res 2021;23(5):e25609

DOI: 10.2196/25609

PMID: 34028361

PMCID: 8185611

Guided internet-based CBT for insomnia: A health-economic evaluation from the societal and public health care perspective alongside a randomized controlled trial

  • Claudia Buntrock; 
  • Dirk Lehr; 
  • Filip Smit; 
  • Hanne Horvath; 
  • Matthias Berking; 
  • Kai Spiegelhalder; 
  • Heleen Riper; 
  • David Daniel Ebert

ABSTRACT

Background:

The evidence base for Internet-based cognitive behavioural therapy for insomnia (iCBT-I) is firm, however little is known about iCBT-I’s health-economic effects.

Objective:

This study aimed to evaluate the cost-effectiveness and cost-utility of iCBT-I to reduce insomnia among employees.

Methods:

Schoolteachers (N = 128) with clinically significant insomnia symptoms and work-related rumination were randomised to guided iCBT-I or a waitlist control group (WLC), both with unrestricted access to treatment-as-usual. Healthcare use, patient and family expenditures and productivity losses were self-assessed and used for costing from a societal and a public health care perspective. Costs were related to symptom-free status (SFS; score < 8 on the insomnia severity index) and quality-adjusted life years (QALYs) gained. Sample error was handled using non-parametric bootstrapping.

Results:

Statistically significant differences favouring the intervention group were found for both clinical outcomes (SFS: yes/no: β = .30, 95% CI .16 - .43); QALYs: β = .019, 95% CI .01 - .03). From a societal perspective, iCBT-I had a 94% probability of dominating WLC for both clinical outcomes. From a public healthcare perspective, iCBT-I was more effective but also more expensive than WLC, resulting in an incremental cost-effectiveness ratio (ICER) of €650 per symptom-free individual. In terms of QALYs, the ICER was €11,285. At a willingness-to-pay threshold of €20,000 per QALY gained, the intervention’s probability of being cost-effective was 89%.

Conclusions:

Our trial indicates that iCBT could be considered as a good value-for-money intervention for insomnia. Clinical Trial: German Clinical Trial Registry: DRKS00004700; Online Recovery Training for better sleep in teachers with high occupational strain; https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00004700 (Archived at: https://web.archive.org/web/20201106094150/https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00004700)


 Citation

Please cite as:

Buntrock C, Lehr D, Smit F, Horvath H, Berking M, Spiegelhalder K, Riper H, Ebert DD

Guided Internet-Based Cognitive Behavioral Therapy for Insomnia: Health-Economic Evaluation From the Societal and Public Health Care Perspective Alongside a Randomized Controlled Trial

J Med Internet Res 2021;23(5):e25609

DOI: 10.2196/25609

PMID: 34028361

PMCID: 8185611

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.